Primary Record
RIFABUTIN
- In stock
- 8,320 g
- Purity
- 99.3 %
- CAS
- 72559-06-9
Compound Identifiers & Properties
- CAS
- 72559-06-9
- PubChem CID
- 135415564
- SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)/C
- Canonical SMILES
- CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(CC(C)C)CC2)N=5)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
Names & Synonyms
- RIFABUTIN
- Ansamycin
- Mycobutin
- Rifabutina
- Rifabutine
- Rifabutinum
- Ansatipine
- Ansatipin
- Alfacid
- Assatipin
- Mycobutin (TN)
- Antibiotic LM 427
- Rifabutine [French]
- Rifabutinum [Latin]
- Rifabutina [Spanish]
- Rifabutin (Standard)
- Rifabutin Pfizer Brand
- RIFABUTIN [INN]
- RIFABUTIN [JAN]
- RIFABUTIN [MI]
- LM 427
- RIFABUTIN [HSDB]
- RIFABUTIN [USAN]
- BV100 (for infusion)
- Rifabutin (JAN/USP/INN)
- RIFABUTIN [VANDF]
- Pfizer Brand of Rifabutin
- Rifabutin [USAN:BAN:INN]
- D05CHI
- RIFABUTIN [MART.]
- Kenfarma Brand of Rifabutin
- RIFABUTIN [USP-RS]
- RIFABUTIN [WHO-DD]
- UNII-1W306TDA6S
- LM-427
- DRG-0085
- Grunenthal Brand of Rifabutin
- Rifabutin [USAN:INN:BAN]
- 72559-06-9
- 4-N-isobutylspiropiperidylrifamycin S
- 1W306TDA6S
- CHEMBL287414
- CHEMBL444633
- RIFABUTIN [ORANGE BOOK]
- DTXSID0033960
- RIFABUTIN [EP MONOGRAPH]
- C46H62N4O11
- CHEBI:45367
- GTPL12015
- HSDB 3577
- RIFABUTIN [USP MONOGRAPH]
- ATEBXHFBFRCZMA-VXTBVIBXSA-N
- TALICIA COMPONENT RIFABUTIN
- LM427
- MSK10867
- BDBM50237607
- HY-17025R
- AKOS015963033
- Rifabutin [USAN:USP:INN:BAN:JAN]
- C46-H62-N4-O11
- CID6323490
- NC00720
- BRN 3584778
- AC-19109
- AN-37420
- R0211
- D00424
- Mycobutin, Ansamycin, LM 427, Ansatipine, Rifabutin
- 1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin XIV
- 4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S
- (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate
- 1',4-Didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxorifamycin XIV
- (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-1'-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethyl-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin
- 1,4-dihydro-1-deoxy-1?,4-didehydro-5?-(2-methylpropyl)-1-oxo-rifamycinxi;1,4-dihydro-1-deoxy-1?,4-didehydro-5?-(2-methylpropyl)-1-oxorifamycinxiv;
- 4-DEOXO-3,4-(2-SPIRO-(N-ISOBUTYL-4-PIPERIDYL))-(1H)-IMIDAZO-(2,5-DIHYDRO)RIFAMYCIN S
- RBT
- RFB
- Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptameth